Updated Jul 16, 2026
Whitehead Warren has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Whitehead Warren is an individual named in Aptose Biosciences Inc.'s SEC filings as of July 1, 2026. Publicly available biographical sources do not provide a detailed personal history for this person. Based on the SEC context, Warren appears to be associated with Aptose Biosciences in an insider capacity as of the most recently disclosed filing date. There is no widely documented information about their education, career trajectory, or other roles beyond the SEC disclosure. Investors should rely on official SEC filings and Aptose investor relations materials for more precise details.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | APTO | Aptose Biosciences Inc. | D — Derivative transaction | 33 | $1.72 | $57 |
Whitehead Warren is an individual named in Aptose Biosciences Inc.'s SEC filings as of July 1, 2026. Publicly available biographical sources do not provide a detailed personal history for this person. Based on the SEC context, Warren appears to be associated with Aptose Biosciences in an insider capacity as of the most recently disclosed filing date. There is no widely document…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Whitehead Warren profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.